<?xml version="1.0"?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2014//EN" "http://www.ncbi.nlm.nih.gov/corehtml/query/DTD/pubmed_140101.dtd">
<PubmedArticle>
    <MedlineCitation Status="In-Process" Owner="NLM">
        <PMID Version="1">31864861</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>07</Month>
            <Day>09</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1989-2284</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>40</Volume>
                    <Issue>3</Issue>
                    <PubDate>
                        <MedlineDate>2020 May - Jun</MedlineDate>
                    </PubDate>
                </JournalIssue>
                <Title>Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia</Title>
                <ISOAbbreviation>Nefrologia</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Impact of hepatitis virus infection on arterial calcification among incident hemodialysis patients.</ArticleTitle>
            <Pagination>
                <MedlinePgn>336-344</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0211-6995(19)30186-9</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.nefro.2019.09.005</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND">The impact of hepatitis virus infection on arterial calcification (AC) was not studied.</AbstractText>
                <AbstractText Label="OBJECTIVE">To study the prevalence, severity and distribution of AC in incident hemodialysis patients with hepatitis B and C viral infection.</AbstractText>
                <AbstractText Label="CASES AND METHODS">172 stage 5 CKD adults (98 male and 74 female) were included; 58 of them were seronegative for both hepatitis B and C (SN group), 48 were positive for hepatitis B virus infection (HBV group) and 66 were hepatitis C virus positive (HCV group). Beside histopathology of the obtained arterial samples, all these cases were examined for body mass index (BMI), serum calcium (Ca), phosphorus (P), alkaline phosphatase (AP), serum albumin, uric acid (UA), alanine transaminase (ALT), parathormone (PTH), fibroblast growth factor 23(FGF23), interleukin 6 (IL6), and 25 hydroxy vitamin D (25 (OH) vit D), hemoglobin concentration, and serum ferritin.</AbstractText>
                <AbstractText Label="RESULTS">86 (50%) of the cases had AC; 11 of them were in SN group (19%), 9 in HBV group (18.8%) and all the 66 HCV group (100%). In SN group, 4 had intimal calcification, 5 had medial calcification, and 2 had both intimal and medial calcification. In HBV group, 9 had intimal calcification, while no cases were encountered with either medial or both site calcifications. In HCV group, 16 had intimal calcification, 31 had medial calcification, and 19 had both intimal and medial calcification. Calcification was in the form of spots in one case in SN group, and 6 cases in HBV group, a single plaque of calcification in 5 cases of SN group, 3 cases of HBV group, and 16 cases of HCV group, multiple plaques were detected in 4 cases in SN group, and 31 cases in HCV group, and diffuse calcification in one case in SN group, and 19 cases in HCV group. In HBV group, calcification was only detected in patients with high viremia, while all patients with low or moderate viremia were devoid of calcification. In HCV group, all patients with low viremia had intimal solitary plaque of calcification, all patients with moderate viremia had multiple plaques of medial calcification, while all patients with high viremia had diffuse intimal and medial calcification. Both groups of viral hepatitis were significantly different in comparison to SN group in either distribution or calcification score (P&lt;0.001 in all). HBV group had significantly lower serum P, CaxP and PTH in comparison to SN group (4.6Â±0.66 vs. 5.45Â±0.77mg/dL, 36.4Â±7.2 vs. 44.1Â±8.69, and 348Â±65.4 vs. 405.9Â±83.2pg/mL, P&lt;0.001, &lt;0.001, and 0.035 respectively). On the other hand, HCV group did not show any significant difference in any of the studied parameters compared to SN group.</AbstractText>
                <AbstractText Label="CONCLUSION">HCV positive patients are more prone to develop AC that is more extensive. HBV positive patients were less likely to have arterial medial calcification, probably related to lower serum phosphorus, CaxP product and PTH. HCV infection should be added as risk factor for AC among CKD patients. Further studies are needed to confirm these findings.</AbstractText>
                <CopyrightInformation>Copyright Â© 2019. Published by Elsevier EspaÃ±a, S.L.U.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Fayed</LastName>
                    <ForeName>Ahmed</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Nephrology unit, Internal Medicine Department, School of Medicine, Cairo University, Egypt.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Soliman</LastName>
                    <ForeName>Ahmed</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Nephrology unit, Internal Medicine Department, School of Medicine, Cairo University, Egypt.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>El Mahdy</LastName>
                    <ForeName>Hossam</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Vascular surgery unit, General Surgery Department, School of Medicine, Cairo University, Egypt.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hamza</LastName>
                    <ForeName>Wael</ForeName>
                    <Initials>W</Initials>
                    <AffiliationInfo>
                        <Affiliation>Pathology Department, School of Medicine, Cairo University, Egypt.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Abdulazim</LastName>
                    <ForeName>Dina O</ForeName>
                    <Initials>DO</Initials>
                    <AffiliationInfo>
                        <Affiliation>Rheumatology and Rehabilitation Department, School of Medicine, Cairo University, Egypt.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Salem</LastName>
                    <ForeName>Mona M</ForeName>
                    <Initials>MM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Endocrinology unit, Internal Medicine Department, School of Medicine, Cairo University, Egypt.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sharaf El Din</LastName>
                    <ForeName>Usama A</ForeName>
                    <Initials>UA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Nephrology unit, Internal Medicine Department, School of Medicine, Cairo University, Egypt. Electronic address: usamaaas@gmail.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <CollectiveName>Vascular Calcification Group (VCG)</CollectiveName>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <Language>spa</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>12</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Spain</Country>
            <MedlineTA>Nefrologia</MedlineTA>
            <NlmUniqueID>8301215</NlmUniqueID>
            <ISSNLinking>0211-6995</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="Y">Arterial biopsy</Keyword>
            <Keyword MajorTopicYN="Y">Biopsia arterial</Keyword>
            <Keyword MajorTopicYN="Y">CKD</Keyword>
            <Keyword MajorTopicYN="Y">CalcificaciÃ³n vascular</Keyword>
            <Keyword MajorTopicYN="Y">ERC</Keyword>
            <Keyword MajorTopicYN="Y">FGF23</Keyword>
            <Keyword MajorTopicYN="Y">FÃ³sforo</Keyword>
            <Keyword MajorTopicYN="Y">Hepatitis B</Keyword>
            <Keyword MajorTopicYN="Y">Hepatitis C</Keyword>
            <Keyword MajorTopicYN="Y">Parathormone</Keyword>
            <Keyword MajorTopicYN="Y">Paratohormona</Keyword>
            <Keyword MajorTopicYN="Y">Phosphorus</Keyword>
            <Keyword MajorTopicYN="Y">Vascular calcification</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>01</Month>
                <Day>26</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>29</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>05</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>12</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>12</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>12</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31864861</ArticleId>
            <ArticleId IdType="pii">S0211-6995(19)30186-9</ArticleId>
            <ArticleId IdType="doi">10.1016/j.nefro.2019.09.005</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>